Dissertation - Shandong Baofa Oncotherapy Corporation Limited

Mokhoa oa Novel Eclectic bakeng sa Therapy ea Mofets'e ka Liquid Knife & Immuno Therapy: UMIPIC, e kanna ea feta Opereishene e ngata, Chemotherapy le Therapy ea Radiation bakeng sa Methati eohle ea Tumor e Tiileng.

Lithethefatsi tse kopantsoeng ke H2 O2 Injection Intratumoral ho fetola Matrix ea Extracellular hore e be Autologous Coagulum joalo ka Depot ea Lithethefatsi.

Tšepo e Ncha ea Phekolo ea Kankere ka Liquid Knife & Immuno Therapy: UMIPIC

Acute Tumor Inflammation e nang le CD4/8+ le CD11+ e Matlafalitsoeng ke Nako ea Nako e Telele ea ho Pholoha Mehatong e Tsoetseng Pele ea lihlahala tse tiileng ka Ultra Minimum Incision Personalized Intratumoral Chemoimmunotehrapy.

Ho ruruha ho Acute ka Ponahalo e Khethehileng ea CD11 & CD4 ho Hlahisa Phello ea Abscopal ka Intramoral Injection Chemotherapy Drug e nang le Hapten ho Mohlala oa liphoofolo.

Nako e Ncha ea Opereishene ea lmmuno ea Tla: Mokhoa oa Novel Eclectic bakeng sa Phekolo ea Kankere ka Liquid Knife & lmmuno Therapy.

Acute Tumor Inflammation e nang le CD4 / 8 + le CD11 + E lelefatsa Phello ea ho Pholoha e Bakiloeng ke Intratumral Injection Optimum Combination of Chemotherapy Drugs le Hydralazine e le Hapten ka Mohlala oa Liphoofolo.

Tsosa Lisele tsa 'mele oa ho itšireletsa mafung ka Hapten e Matlafalitsoeng ka Intratumoral Chemotherapy ka Penicillin Prolong Pancreatic Cancer Survival.

Ho lebela ka katleho sebakeng sa antigen ea nyutlelie ea oncogenic ka tumor e amanang le li-autoantibodies (iTAA)

Liphetoho tsa 'mele oa ho itšireletsa mafung tse bakoang ke Intratumoral Hapten Plus Chemotherapy Lithethefatsi tsa EndometrialCancer.

Tokisetso ea Kankere ea Immunotherapy le Ts'ebetso ea Lisele tsa 'mele ka Hapten-Enhanced Chemotherapy ho Kankere ea Matšoafo ea Matšoafo.

K'hemik'hale ea 'mele ea ho itšireletsa mafung ea maqeba a mabe a popelo a tsosang lisele tsa' mele oa 'mele le ho khutlisetsa HPV e tloaelehileng e mpe le e sa tloaelehang.

Phello ea sodium stibogluconate ho bokella le ho tsosa lisele tsa 'mele tsa ho itšireletsa mafung ka har'a mokelikeli oa mofetše oa mofetše oa pancreatic: ho itokisetsa immunotherapy.

Sebelisa scRNA-Seq Profile ho Hlalosa Immunologic Response after Intra-tumor Hapen Enhanced Chemotherapy Tabeng ea Intracranial Anaplastic Hemangiopericytoma Liver Metastasis: Tlaleho ea Nyeoe

Hapten-Mediated Chemical Immune Therapy e nang le Tsamaiso ea Lithethefatsi ho Kankere ea Molomo ntle le Hysterectomy: Lisele Tse Tsosang tsa Immune bakeng sa Immunotherapy.

Ho sibolloa ha biomarker ho hepatocellular carcinoma (HCC) bakeng sa kalafo ea motho ka mong le prognosis e ntlafalitsoeng.

Phatlalatso

Phatlalatso

Ke kopa o re siele molaetsa